KNTE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 41.70%

Insider Buying (Last 12 Months): $9,074,491.04

Insider Selling (Last 12 Months): $0.00

Kinnate Biopharma Insider Trading History Chart

Kinnate Biopharma Share Price & Price History

^$2.65

▼ -0.01 (-0.38%)

As of 04/3/2024 09:00 PM ET

Days: 30 | 90 | 365

Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS

From Paradigm Press | Ad

You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better.

Click here to find out that this 8,788% cryptocurrency is.

Kinnate Biopharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/8/2023	James B Tananbaum	Director	Buy	1,780,000	$2.80	$4,984,000.00	3,525,957
5/4/2023	Orbimed Advisors Llc	Director	Buy	479,909	$2.75	$1,319,749.75	4,738,453
5/1/2023	Carl L. Gordon	Director	Buy	716,157	$2.62	$1,876,331.34	4,204,852
4/28/2023	Carl L. Gordon	Director	Buy	350,749	$2.55	$894,409.95	3,737,784
3/14/2022	Richard Thomas Williams	Insider	Buy	25,000	$8.37	$209,250.00
3/11/2022	Richard Thomas Williams	Insider	Buy	15,000	$8.64	$129,600.00
2/14/2022	Carl L. Gordon	Director	Buy	30,700	$9.95	$305,465.00
2/11/2022	Carl L. Gordon	Director	Buy	156,000	$10.22	$1,594,320.00

Did You Get Your Free Bitcoin Yet?

From Crypto Swap Profits | Ad

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

SEC Filings (Institutional Ownership Changes) for Kinnate Biopharma (NASDAQ:KNTE)

80.89% of Kinnate Biopharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Kinnate Biopharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/23/2024	BML Capital Management LLC	498,851	$1.33M	0.9%	+6.5%	1.056%
4/17/2024	Deltec Asset Management LLC	1,039,800	$2.77M	0.5%	N/A	2.202%
2/14/2024	Pale Fire Capital SE	220,555	$0.52M	0.1%	+214.3%	0.468%
2/9/2024	Dynamic Technology Lab Private Ltd	13,891	$33K	0.0%	N/A	0.029%
2/2/2024	Marquette Asset Management LLC	59,961	$0.14M	0.0%	N/A	0.127%
2/2/2024	Acuitas Investments LLC	289,766	$0.69M	0.3%	N/A	0.615%
2/2/2024	BML Capital Management LLC	468,210	$1.11M	0.8%	N/A	0.994%
1/30/2024	BML Capital Management LLC	446,874	$1.06M	0.8%	N/A	0.949%
12/6/2023	Citigroup Inc.	420,585	$0.59M	0.0%	+53,138.6%	0.893%
11/15/2023	Rock Springs Capital Management LP	405,811	$0.57M	0.0%	-45.7%	0.861%
11/14/2023	Lynx1 Capital Management LP	1,997,006	$2.80M	1.8%	-2.5%	4.240%
11/14/2023	Pale Fire Capital SE	70,174	$98K	0.0%	+196.3%	0.149%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	52,168	$73K	0.0%	N/A	0.111%
11/13/2023	Acadian Asset Management LLC	736,686	$1.03M	0.0%	+71.0%	1.564%
11/9/2023	Citigroup Inc.	420,585	$0.59M	0.0%	+53,138.6%	0.893%
9/21/2023	Barclays PLC	14,568	$44K	0.0%	-50.5%	0.031%
8/15/2023	Boxer Capital LLC	491,000	$1.49M	0.1%	-3.7%	1.042%
8/14/2023	Prelude Capital Management LLC	28,754	$87K	0.0%	N/A	0.061%
8/11/2023	Pale Fire Capital SE	23,682	$72K	0.0%	N/A	0.050%
8/11/2023	Harvard Management Co. Inc.	462,418	$1.40M	0.1%	-7.1%	0.982%
8/11/2023	Foresite Capital Management V LLC	3,525,957	$10.68M	7.8%	+78.5%	7.486%
8/7/2023	Acadian Asset Management LLC	430,802	$1.30M	0.0%	+1,389.9%	0.925%
7/27/2023	Virtu Financial LLC	20,585	$62K	0.0%	N/A	0.044%
7/21/2023	Creative Planning	12,257	$37K	0.0%	N/A	0.026%
5/16/2023	Ally Bridge Group NY LLC	109,393	$0.68M	0.9%	N/A	0.235%
5/12/2023	Foresite Capital Management V LLC	1,975,001	$12.34M	9.1%	+125.7%	4.241%
4/27/2023	Simplex Trading LLC	12,089	$75K	0.0%	+1,956.0%	0.026%
2/14/2023	Boxer Capital LLC	510,000	$3.11M	0.2%	-66.5%	1.155%
2/13/2023	Martingale Asset Management L P	22,522	$0.14M	0.0%	N/A	0.051%
2/13/2023	GSA Capital Partners LLP	70,174	$0.43M	0.1%	-4.2%	0.159%
2/9/2023	Victory Capital Management Inc.	71,020	$0.43M	0.0%	-38.5%	0.161%
2/7/2023	State Board of Administration of Florida Retirement System	14,254	$87K	0.0%	-26.2%	0.032%
2/2/2023	SG Americas Securities LLC	10,435	$64K	0.0%	-12.4%	0.024%
11/15/2022	Boxer Capital LLC	1,522,559	$18.20M	1.0%	-17.6%	3.447%
11/2/2022	Victory Capital Management Inc.	115,550	$1.38M	0.0%	-2.5%	0.262%
10/5/2022	Vida Ventures Advisors LLC	2,207,772	$26.38M	23.7%	-19.6%	5.001%
8/16/2022	Western Standard LLC	102,780	$1.30M	1.0%	N/A	0.233%
8/16/2022	DAFNA Capital Management LLC	224,451	$2.83M	0.8%	+51.5%	0.508%
8/16/2022	Deerfield Management Company L.P. Series C	250,000	$3.15M	0.1%	-74.6%	0.566%
8/11/2022	Trexquant Investment LP	13,420	$0.17M	0.0%	N/A	0.031%
8/5/2022	State Board of Administration of Florida Retirement System	19,304	$0.24M	0.0%	N/A	0.044%
8/1/2022	Victory Capital Management Inc.	118,530	$1.50M	0.0%	+37.8%	0.270%
7/29/2022	SG Americas Securities LLC	11,642	$0.15M	0.0%	N/A	0.026%
6/30/2022	Amalgamated Bank	3,172	$36K	0.0%	N/A	0.007%
5/17/2022	RA Capital Management L.P.	4,264,144	$48.01M	1.0%	+18.7%	9.698%
5/11/2022	American Century Companies Inc.	319,527	$3.60M	0.0%	+49.6%	0.727%
5/11/2022	GSA Capital Partners LLP	47,175	$0.53M	0.1%	N/A	0.107%
5/4/2022	Victory Capital Management Inc.	86,040	$0.97M	0.0%	-25.9%	0.196%
2/14/2022	Citadel Advisors LLC	1,121,704	$19.88M	0.0%	-2.8%	2.567%
2/14/2022	Virtus ETF Advisers LLC	9,725	$0.17M	0.1%	N/A	0.022%
2/14/2022	Deerfield Management Company L.P. Series C	985,568	$17.46M	0.4%	-4.2%	2.256%
2/14/2022	Nextech Invest AG	3,008,243	$53.31M	12.4%	N/A	6.884%
2/14/2022	Novo Holdings A S	553,128	$9.80M	0.5%	+11.0%	1.266%
2/11/2022	Foresite Capital Opportunity Management V LLC	291,667	$5.17M	3.5%	N/A	0.667%
2/8/2022	ProShare Advisors LLC	11,778	$0.21M	0.0%	N/A	0.027%
2/8/2022	Northern Trust Corp	213,537	$3.78M	0.0%	+1.0%	0.489%
2/7/2022	Victory Capital Management Inc.	116,140	$2.06M	0.0%	+21.9%	0.266%
2/7/2022	SG Americas Securities LLC	7,707	$0.14M	0.0%	-49.9%	0.018%
2/7/2022	American Century Companies Inc.	213,645	$3.79M	0.0%	+22.9%	0.489%
2/2/2022	New York State Common Retirement Fund	18,817	$0.33M	0.0%	+78.6%	0.043%
1/31/2022	Dupont Capital Management Corp	8,804	$0.16M	0.0%	-28.5%	0.020%
1/21/2022	Russell Investments Group Ltd.	55,568	$0.98M	0.0%	+147.5%	0.127%
11/22/2021	EcoR1 Capital LLC	175,000	$4.03M	0.1%	+600.0%	0.400%
11/16/2021	Janus Henderson Group PLC	127,027	$2.92M	0.0%	-78.9%	0.291%
11/16/2021	Metropolitan Life Insurance Co NY	7,510	$0.17M	0.0%	N/A	0.017%
11/16/2021	Millennium Management LLC	118,734	$2.73M	0.0%	N/A	0.272%
11/16/2021	Boxer Capital LLC	1,847,559	$42.53M	1.5%	+73.3%	4.230%
11/16/2021	Citadel Advisors LLC	1,154,273	$26.57M	0.0%	-11.3%	2.643%
11/15/2021	Point72 Hong Kong Ltd	1,862	$43K	0.0%	N/A	0.004%
11/15/2021	Deerfield Management Company L.P. Series C	1,028,508	$23.68M	0.5%	+0.8%	2.355%
11/15/2021	California State Teachers Retirement System	22,837	$0.53M	0.0%	+22.1%	0.052%
11/15/2021	Rock Springs Capital Management LP	332,986	$7.67M	0.2%	+0.4%	0.762%
11/15/2021	HighVista Strategies LLC	60,905	$1.40M	0.9%	+82.4%	0.139%
11/15/2021	Voya Investment Management LLC	9,198	$0.21M	0.0%	N/A	0.021%
11/12/2021	Renaissance Technologies LLC	23,358	$0.54M	0.0%	-34.9%	0.053%
11/12/2021	The Manufacturers Life Insurance Company	13,805	$0.32M	0.0%	N/A	0.032%
11/12/2021	Geode Capital Management LLC	337,222	$7.76M	0.0%	+42.1%	0.772%
11/10/2021	Goldman Sachs Group Inc.	94,561	$2.18M	0.0%	+521.6%	0.217%
11/10/2021	Citigroup Inc.	3,798	$87K	0.0%	+170.7%	0.009%
11/9/2021	BlackRock Inc.	1,874,361	$43.15M	0.0%	+47.2%	4.291%
11/8/2021	Russell Investments Group Ltd.	22,455	$0.52M	0.0%	N/A	0.051%
11/4/2021	Deutsche Bank AG	132,866	$3.06M	0.0%	+5.2%	0.304%
11/3/2021	Dupont Capital Management Corp	12,315	$0.28M	0.0%	N/A	0.028%
11/2/2021	New York State Common Retirement Fund	10,538	$0.24M	0.0%	-19.6%	0.024%
11/2/2021	Victory Capital Management Inc.	95,270	$2.19M	0.0%	-0.8%	0.218%
11/1/2021	SG Americas Securities LLC	15,385	$0.35M	0.0%	N/A	0.035%
10/19/2021	JJJ Advisors Inc.	990	$35K	0.0%	N/A	0.002%
8/17/2021	Woodline Partners LP	260,276	$6.06M	0.1%	-9.0%	0.598%
8/17/2021	Logos Global Management LP	1,329,602	$30.95M	2.6%	+42.3%	3.056%
8/17/2021	Price T Rowe Associates Inc. MD	445,477	$10.37M	0.0%	-31.3%	1.024%
8/17/2021	Citadel Advisors LLC	1,300,887	$30.29M	0.0%	-1.1%	2.990%
8/16/2021	Squarepoint Ops LLC	13,272	$0.31M	0.0%	N/A	0.031%
8/16/2021	California State Teachers Retirement System	18,707	$0.44M	0.0%	-8.2%	0.043%
8/16/2021	Charles Schwab Investment Management Inc.	90,050	$2.10M	0.0%	+1.6%	0.207%
8/16/2021	State Street Corp	237,130	$5.52M	0.0%	+29.4%	0.545%
8/16/2021	Nuveen Asset Management LLC	57,743	$1.34M	0.0%	+17.4%	0.133%
8/16/2021	Goldman Sachs Group Inc.	15,212	$0.35M	0.0%	-14.4%	0.035%
8/13/2021	Renaissance Technologies LLC	35,900	$0.84M	0.0%	N/A	0.083%
8/13/2021	Northern Trust Corp	135,513	$3.16M	0.0%	-6.9%	0.311%
8/13/2021	Franklin Resources Inc.	192,100	$4.47M	0.0%	+9.8%	0.442%

Data available starting January 2016

Kinnate Biopharma Inc., a clinical-stage oncology company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors FGFR2 and FGFR3 genes; and small molecule research programs, including Cyclin-Dependent Kinase 12(CDK12) inhibitor in its KIN004 program. The company was incorporated in 2018 and is headquartered in San Francisco, California. Kinnate Biopharma Inc. is a former subsidiary of Fount Therapeutics, LLC.

Today's Range

Now: $2.65

$2.64

$2.68

50 Day Range

MA: $2.60

$2.43

$2.66

52 Week Range

Now: $2.65

$1.04

$7.18

Volume

2,812,200 shs

Average Volume

418,678 shs

Market Capitalization

$125.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.38

Who are the company insiders with the largest holdings of Kinnate Biopharma?: Kinnate Biopharma's top insider investors include:
Orbimed Advisors Llc (Director)
Carl L Gordon (Director)
James B Tananbaum (Director)
Learn More about top insider investors at Kinnate Biopharma.
Who are the major institutional investors of Kinnate Biopharma?: Kinnate Biopharma's top institutional shareholders include:
Deltec Asset Management LLC — 2.20%
BML Capital Management LLC — 1.06%
Learn More about top institutional investors of Kinnate Biopharma stock.
Which institutional investors are buying Kinnate Biopharma stock?: During the previous quarter, KNTE stock was bought by institutional investors including:
Deltec Asset Management LLC
BML Capital Management LLC
In the last year, these company insiders have bought Kinnate Biopharma stock:
Orbimed Advisors Llc (Director)
Carl L Gordon (Director)
James B Tananbaum (Director)
Learn More investors buying Kinnate Biopharma stock.